Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) Cost of Revenue (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Cost of Revenue for 16 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Cost of Revenue changed 0.19% to $1.7 million in Q4 2025 year-over-year; TTM through Nov 2025 was $7.4 million, a 7.19% decrease, with the full-year FY2025 number at $7.4 million, down 7.19% from a year prior.
  • Cost of Revenue was $1.7 million for Q4 2025 at Cryo Cell International, down from $1.8 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $2.5 million in Q3 2021 to a low of $1.7 million in Q4 2024.
  • A 5-year average of $2.1 million and a median of $2.1 million in 2022 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: decreased 19.61% in 2021, then increased 4.52% in 2022.
  • Cryo Cell International's Cost of Revenue stood at $2.3 million in 2021, then dropped by 6.84% to $2.1 million in 2022, then fell by 5.38% to $2.0 million in 2023, then dropped by 14.48% to $1.7 million in 2024, then increased by 0.19% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Cost of Revenue are $1.7 million (Q4 2025), $1.8 million (Q3 2025), and $1.9 million (Q2 2025).